In our previous studies with lung cancer cell lines, we detected a positive correlation between HER-2/neu expression by IHC and effectiveness of treatment with trastuzumab alone or in combination with cytostatic drugs (Bunn et al, 2001). This evidence concerns the gene ERBB2 and lung carcinoma.